Levofloxacin (Levaquin)

Category:

  • Antibiotic

Description:

  • Fluoroquinolone antibiotic

Indications:

  • Acute maxillary sinusitis (S. pneumoniae, H. influenzae, M. catarrhalis)

  • Acute bacterial exacerbation of chronic bronchitis (H. influenzae, H. parainfluenzae, M. catarrhalis, S. aureus, S. pneumoniae)

  • Community-acquired pnemonia (S. aureus, S. pneumoniae, H. influenzae, H. parainfluenzae, K. pneumoniae,M. catarrhalis, Chlamydia pneumoniae, Legionella pneumophila,Mycoplasma pneumoniae)

  • Skin infections (S. pyogenes, S. aureus)

  • Complicate urinary tract infections (Enterbacter cloacae, Enterococcus faecalis, E. coli, K. pneumoniae, P. mirabilis, P. aeruginosa)

  • Uncomplicated urinary tract infections (E. coli, K. pneumoniae, S. saprophyticus)

  • Acute pyelonephritis (E. coli)

Contraindications:

  • None

Precautions:

  • Pregnancy category C

  • May cause photosensitivity reactions

  • May cause pseudomembranous colitis

  • Do not use in young children due to possible cartilage abnormalities

  • May cause ophthalmologic abnormalities

  • Administer on an empty stomach

  • Do not take with antacids, iron, aluminum, magnesium or zinc preparations, milk or dairy products, take 2 hours before or 2 hours after

  • May cause dizziness or lightheadedness, use caution when performing tasks

  • Take each dose with a full glass of water

  • Complete full course of therapy

  • Administer by IV infusion only over a period of not less than 60 minutes, DO NOT administer by IM, intrathecal, intraperitoneal or SQ

  • Dosage modifications are required in patients with renal impairment

Adverse Reactions (Side Effects):

  • Bad taste in mouth

  • Nausea, anorexia

  • Headache, dizziness, insomnia, restlessness

Dosage:

  • Administered orally (tablets) and by IV injection

  • Acute bacterial exacerbation of chronic bronchitis: 

    • 500mg po q24h for 7 days

  • Community-acquired pneumonia: 

    • 500mg po q24h for 7-14 days

  • Acute maxillary sinusitis: 

    • 500mg po q24h for 10-14 days

  • Uncomplicated skin infection: 

    • 500mg po q24h for 7-10 days

  • Complicated UTIs: 

    • 250mg po q24h for 10 days

  • Uncomplicated UTIs: 

    • 250mg po q24h for 3 days

  • Acute pyelonephritis: 

    • 250mg po q24h for 10 days

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site